Skip to main content
Midas Edge

13-F holdings, Q2 2026

Lion Point Capital, LP

A 13-F is the report large US investment managers file with the SEC each quarter, listing the stocks they held at quarter end.

Reported value
$20.9M
Positions
35
Filed
Data as of

These holdings are as of , 138 days ago.

13-Fs for Q3 2026 are due by .

Read filingRead the filing on SEC.gov

See this manager's Holder IQ and how the book overlaps yours

Free to start, with no card. Holder IQ scores a manager's past record. It describes the past and is not a recommendation to buy or sell anything. Sign up and you can follow this manager: one notice for each new 13-F, naming what changed and which of those positions you hold or watch.

Start freeAlready have an account? Sign in

Top holdings

  1. CUE$1.7M
    52,928 shares8% of the book
  2. PRAX$1.5M
    4,450 shares7.1% of the book
  3. MLTX$1.3M
    67,500 shares6.3% of the book
  4. FENC$1.2M
    112,434 shares5.8% of the book
  5. RPRX$1.2M
    21,400 shares5.7% of the book
  6. CMPS$1.1M
    80,000 shares5.4% of the book
  7. MIST$1.1M
    820,000 shares5.3% of the book
  8. BNTC$829.6K
    62,000 shares4% of the book
  9. SNDX$787K
    36,000 shares3.8% of the book
  10. BHVN$769.3K
    51,700 shares3.7% of the book

What changed this quarter

0 new positions and 0 sold out, against Q1 2026. Added and trimmed positions use the change in split-adjusted shares at the Q2 2026 implied price; full exits use their Q1 2026 reported value, not sale proceeds.

Largest buys

No buys reported against the prior quarter.

Largest sells

  • CUE

    CUE BIOPHARMA INC

    −$647K

    -27.9% shares

    Your stake and evidence for CUE

    What it means for you

    This public view does not read your holdings or watchlist; open the member view to check your stake.

    Use this to decide what to research, rather than as an instruction to copy a trade.

    What happened

    Reported shares decreased between Q1 2026 and Q2 2026.

    Displayed change: −$647K. The current book reports 52,928 shares.

    Why it can matter

    A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.

    How we got this

    For an added or trimmed position, subtract split-adjusted prior shares from current shares, then multiply by the current book's reported value per share; this is not the execution price.

    52,928 current shares − 73,428.467 prior shares on the same basis = -20,500.467 shares.

    Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.

    Where the data comes from

    SEC 13F quarter-end holdings for Q1 2026 and Q2 2026; these delayed disclosures omit shorts and many other assets.

    Current source filed .

    Read source filing

    Source filing on SEC.gov

    Technical details

    Reported dollar change: -646994.8519447801 USD. Current reported shares: 52928. Prior shares on current basis: 73428.46666666666.

All of this comes from the filer's public SEC filings. A 13-F shows long positions in US-listed securities at quarter end and can leave out short positions, cash and non-US holdings, so it is not the whole portfolio. This is filing data, not investment advice.